Seminars in Nuclear Medicine
Volume 33, Issue 3 , Pages 228-237 , July 2003

Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography—clinical use, interpretation methods, diagnostic improvements

References 

  1. Czernin J, Phelps ME. Positron emission tomography scanning: Current and future applications. Annu Rev Med. 2002;53:89–112
  2. Hustinx R, Benard F, Alavi A. Whole-body FDG-PET imaging in the management of patients with cancer. Semin Nucl Med. 2002;32:35–46
  3. Townsend DW. A combined PET/CT scanner: The choices. J Nucl Med. 2001;42:533–534
  4. Ell PJ, Von Schulthess GK. PET/CT: A new road map. Eur J Nucl Med Mol Imaging. 2002;29:719–720
  5. Beyer T, Townsend DW, Brun T, et al.  A combined PET/CT scanner for clinical oncology. J Nucl Med. 2000;41:1369–1379
  6. Burger C, Goerres G, Schoenes S, et al.  PET attenuation coefficients from CT images: Experimental evaluation of the transformation of CT into PET 511-keV attenuation coefficients. Eur J Nucl Med Mol Imaging. 2002;29:922–927
  7. Kamel E, Hany TF, Burger C, et al.  CT vs 68Ge attenuation correction in a combined PET/CT system: Evaluation of the effect of lowering the CT tube current. Eur J Nucl Med Mol Imaging. 2002;29:346–350
  8. Hany TF, Steinert HC, Goerres GW, et al.  PET Diagnostic accuracy: Improvement with In-Line PET-CT system: Initial results. Radiology. 2002;225:575–581
  9. Nakamoto Y, Osman M, Cohade C, et al.  PET/CT: Comparison of quantitative tracer uptake between germanium and CT Transmission attenuation-corrected images. J Nucl Med. 2002;43:1137–1143
  10. Dizendorf EV, Treyer V, Von Schulthess GK, et al.  Application of oral contrast media in coregistered positron emission tomography-CT. AJR Am J Roentgenol. 2002;179:477–481
  11. Cohade C, Osman M, Nakamoto Y, et al.  Initial experience with oral contrast in PET-CT: Phantom and clinical studies. J Nucl Med. 2003;44:412–416
  12. Nakamoto Y, Chin BB, Kraitchman LP, et al.  Effect of non-ionic intravenous contrast agents on PET/CT: Phantom and canine studies. J Nucl Med. 2002;43:13P; (abstr)
  13. Antoch G, Freudenberg LS, Egelhof T, et al.  Focal tracer uptake: A potential artifact in contrast-enhanced dual-modality PET/CT scans. J Nucl Med. 2002;43:1339–1342
  14. Goerres GW, Hany TF, Kamel E, et al.  Head and neck imaging with PET and PET/CT: Artifacts from dental metallic implants. Eur J Nucl Med Mol Imaging. 2002;29:367–370
  15. Cohade C, Osman M, Marshall LT, et al.  Metallic objects artifacts on PET-CT: Clinical and phantom studies. J Nucl Med. 2002;43:308P; (abstr)
  16. Osman MM, Cohade C, Nakamoto Y, et al.  Respiratory motion artifacts on PET emission images obtained using CT attenuation correction on PET-CT. Eur J Nucl Med Mol Imaging. 2003;30:603–606
  17. Osman MM, Cohade C, Nakamoto Y, et al.  Clinically significant inaccurate localization of lesions with PET-CT: Frequency in 300 patients. J Nucl Med. 2003;44:240–243
  18. Cohade C, Osman M, Marshall LN, et al.  PET-CT: Accuracy of PET and CT spatial registration of lung lesions. Eur J Nucl Med Mol Imaging. 2003;30:721–726
  19. Goerres GW, Kamel E, Seifert B, et al.  Accuracy of image coregistration of pulmonary lesions in patients with non-small cell lung cancer using an integrated PET/CT system. J Nucl Med. 2002;43:1469–1475
  20. Goerres GW, Kamel E, Heidelberg TN, et al.  PET-CT image co-registration in the thorax: Influence of respiration. Eur J Nucl Med Mol Imaging. 2002;29:351–360
  21. Charron M, Beyer T, Bohnen NN, et al.  Image analysis in patients with cancer studied with a combined PET and CT scanner. Clin Nucl Med. 2000;25:905–910
  22. Hany TF, Gharehpapagh E, Kamel EM, et al.  Brown adipose tissue: A factor to consider in symmetrical tracer uptake in the neck and upper chest region. Eur J Nucl Med Mol Imaging. 2002;29:1393–1398
  23. Cohade C, Osman M, Pannu HK, et al.  Uptake in the supraclavicular area fat (USA fat): Description on 18F-FDG PET-CT. J Nucl Med. 2003;44:170–176
  24. Kluetz PG, Meltzer CC, Villemagne VL, et al.  Combined PET/CT Imaging in Oncology. Impact on Patient Management. Clin Positron Imaging. 2000;3:223–230
  25. Goerres GW, Von Schulthess GK, Hany TF. Positron emission tomography and PET CT of the head and neck: FDG uptake in normal anatomy, in benign lesions, and in changes resulting from treatment. AJR Am J Roentgenol. 2002;179:1337–1343
  26. Heller MT, Meltzer CC, Fukui MB, et al.  Superphysiologic FDG uptake in the non-paralyzed vocal cord. Resolution of a false-positive PET Result with combined PET-CT imaging. Clin Positron Imaging. 2000;3:207–211
  27. Kamel EM, Goerres GW, Burger C, et al.  Recurrent laryngeal nerve palsy in patients with lung cancer: Detection with PET-CT image fusion---Report of six cases. Radiology. 2002;224:153–156
  28. Vansteenkiste JF, Stroobants SG, Dupont PJ, et al.  FDG-PET scan in potentially operable non-small cell lung cancer: Do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases? The Leuven Lung Cancer Group. Eur J Nucl Med. 1998;25:1495–1501
  29. Wahl RL, Quint LE, Greenough RL, et al.  Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: Preliminary prospective evaluation. Radiology. 1994;191:371–377
  30. Osman M, Cohade C, Leal J, et al.  Direct comparison of FDG-PET and PET-CT imaging in staging and restaging patients with lung cancer. J Nucl Med. 2002;43:151P; (abstr)
  31. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: Physiologic and benign variants. Radiographics. 1999;19:61–77 quiz 150-151
  32. Cohade C, Osman M, Leal J, et al.  Direct comparison of FDG PET and PET-CT imaging in colorectal cancer. J Nucl Med. 2002;43:22P; (abstr)
  33. Makhija S, Howden N, Edwards R, et al.  Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: A retrospective review. Gynecol Oncol. 2002;85:53–58
  34. Kinkel K, Lu Y, Both M, et al.  Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): A meta-analysis. Radiology. 2002;224:748–756
  35. Berger KL, Nicholson SA, Dehdashti F, et al.  FDG PET evaluation of mucinous neoplasms: Correlation of FDG uptake with histopathologic features. AJR Am J Roentgenol. 2000;174:1005–1008
  36. Miyakita H, Tokunaga M, Onda H, et al.  Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer. Int J Urol. 2002;9:15–18
  37. Bury T, Barreto A, Daenen F, et al.  Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer. Eur J Nucl Med. 1998;25:1244–1247
  38. Wu HC, Yen RF, Shen YY, et al.  Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphate bone scan to detect bone metastases in patients with renal cell carcinomas—A preliminary report. J Cancer Res Clin Oncol. 2002;128:503–506
  39. Cook GJ, Houston S, Rubens R, et al.  Detection of bone metastases in breast cancer by 18FDG PET: Differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol. 1998;16:3375–3379
  40. Osman M, Cohade C, Fishman EK, et al.  Clinically significant incidental findings on non-contrast CT portion of PET-CT studies: Frequency in 250 patients. J Nucl Med. 2002;43:307P; (abstr)

☆ Address reprint requests to Richard L. Wahl, MD, Division of Nuclear Medicine, the Johns Hopkins Hospital, The Russell H. Morgan Department of Radiology and Radiological Sciences, 601 N. Caroline Street, Room 3223, Baltimore, MD 21287-0817.

☆☆ 0001-2998/03/3303-0001$30.00/0

PII: S0001-2998(03)70008-7

doi: 10.1053/snuc.2003.127312

Seminars in Nuclear Medicine
Volume 33, Issue 3 , Pages 228-237 , July 2003

Article Tools

* Image Usage & Resolution